NetworkNewsBreaks Archive - Page 145 of 2117

MondayJun 30, 2025 1:09 pm

NetworkNewsBreaks – Why Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company, is leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR(R) (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing a pipeline of precision cancer therapies. “Lantern Pharma’s AI-driven RADR(R) platform integrates over 200 billion oncology-specific data points and underpins every stage of its precision oncology pipeline,” reads a recent article. “The company has three lead drug candidates in clinical development, targeting major oncology markets including non-small cell lung cancer (‘NSCLC’), triple-negative breast cancer (‘TNBC’), and non-Hodgkin’s lymphoma (‘NHL’)… Starlight Therapeutics extends Lantern’s footprint into…

MondayJun 30, 2025 12:57 pm

NetworkNewsBreaks – ONAR Holding Corp. (OTCQB: ONAR) Details Q1 Growth, Strategic Focus in Shareholder Letter

ONAR (OTCQB: ONAR) issued a shareholder letter highlighting 79% year-over-year revenue growth in Q1 2025 to $1.07 million, driven by its strategic acquisition and integration of Integrum Group, now rebranded as ONAR LLC. The company emphasized its sharpened focus on high-margin, technology-enabled marketing services through Storia and Of Kos, with 90% of advertising and marketing revenue recurring. ONAR aims to achieve platform-scale profitability by executing pending acquisitions and absorbing fixed public company costs. The letter also outlined ongoing capital structure optimization and reaffirmed the company’s commitment to long-term value creation in the evolving digital marketing landscape. To read the full…

MondayJun 30, 2025 12:22 pm

NetworkNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Appoints Andrew Mavliev as Chief Technology and Product Officer

HealthLynked (OTCQB: HLYK), a connected healthcare technology company, has named Andrew Mavliev as its new Chief Technology and Product Officer. Mavliev, a seasoned executive with over 15 years of experience in technology strategy and product development, previously served as founding CTO of Aram Meem LLC’s ToYou superapp. At HealthLynked, he will lead efforts to expand its AI-powered healthcare platform, telehealth services, and integrated medical record systems. CEO Dr. Michael Dent praised Mavliev’s track record of scaling secure, compliant DTC platforms, saying his leadership will support the company’s push for more accessible and personalized care. To view the full press release,…

MondayJun 30, 2025 10:22 am

NetworkNewsBreaks – Channelchek by Noble Highlights AZZ (NYSE: AZZ) Hikes Dividend Ahead of Q1 FY26 Results

Channelchek, a Noble Financial Group, Inc. product and service, reports that AZZ (NYSE: AZZ) announced a 17.6% increase in its quarterly cash dividend to $0.20 per share, or $0.80 annually, up from $0.17 per share, or $0.68 annually. The dividend is payable July 31 to shareholders of record as of July 10, reflecting management’s confidence in AZZ’s near- and long-term outlook. AZZ will report first-quarter fiscal 2026 results after market close on Wednesday, July 9, with a conference call scheduled for Thursday, July 10, at 11:00 a.m. ET. Investors look forward to updates on the ramp-up of the company’s new…

MondayJun 30, 2025 9:30 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs

Clene (NASDAQ: CLNN) announced key regulatory developments following a Type C meeting with the FDA, where it received feedback on its statistical analysis plan (SAP) for evaluating neurofilament light (NfL) biomarker data from its Expanded Access Protocol for ALS. The company has resubmitted a revised SAP and anticipates FDA acceptance this summer, with NfL analyses scheduled for early Q4 2025 to support a potential NDA submission under the accelerated approval pathway. Clene also confirmed two additional FDA meetings in Q3 2025: one to assess long-term ALS survival data for accelerated approval consideration and another End-of-Phase 2 Type B meeting to review…

MondayJun 30, 2025 9:20 am

NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Issues CEO Update, Reaffirms Commitment to Growth Following Leadership Transition

NextPlat (NASDAQ: NXPL, NXPLW) released a shareholder letter from Interim CEO expressing confidence in the company’s future following the recent passing of CEO and Chairman Charles M. Fernandez. The letter highlights internal reviews, meetings with subsidiary leaders, and plans for increased focus, coordination, and strategic investment to build on the company’s existing foundation and drive long-term value creation. To view the full press release, visit: https://nnw.fm/HA9yZ About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company intends to assist…

FridayJun 27, 2025 3:17 pm

NetworkNewsBreaks – Powering AI: Nicola Mining Inc.’s (TSX.V: NIM) (OTCQB: HUSIF) Copper Project Aligns with Data Center Surge

As artificial intelligence (“AI”) continues to revolutionize industries, the infrastructure supporting its growth has become increasingly reliant on copper due to its superior electrical conductivity. Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) is strategically positioned to supply this growing demand through its New Craigmont Copper Project in British Columbia. “This wholly owned project encompasses a historic high-grade copper mine with significant exploration potential. The company’s focus on copper aligns with the increasing requirements of data centers, particularly those optimized for AI workloads,” reads a recent article. “Nicola Mining’s commitment to responsible development and operational excellence further enhances its capability to supply high-quality copper…

FridayJun 27, 2025 11:02 am

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Featured in NetworkNewsAudio as It Advances Toward Production in Abitibi Gold Belt

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) is the focus of a new Audio Press Release (APR) from NetworkNewsAudio titled "From Exploration to Execution: New Gold Player Emerges in One of Canada’s Premier Mining Districts." The APR highlights LaFleur’s push toward near-term production in Québec’s Abitibi Gold Belt, supported by its fully permitted Beacon Gold Mill and 100%-owned Swanson Gold Project. Positioned to capitalize on record gold prices surpassing US$3,300 per ounce, LaFleur plans to restart its 750 tpd mill by late 2025 to generate cash flow through bulk sampling and custom milling. With a compliant gold resource exceeding…

FridayJun 27, 2025 10:20 am

NetworkNewsBreaks – InvestorNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Highlights 2025 Pipeline Progress and Strategic Focus in Shareholder Letter

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech company developing systemic oncolytic targeted immunotherapies, released a shareholder letter from CEO Eric Poma, PhD, outlining a transformative year for the company. Since Poma’s appointment in April 2025 and the addition of Dr. Guy Travis Clifton as Chief Medical Officer, Calidi has streamlined operations and advanced its RedTail platform—a systemically delivered virotherapy designed to target metastatic cancers and deliver genetic payloads. Preclinical data presented at AACR and ASCO showcased RedTail’s tumor selectivity and immune modulation potential, driving partnership discussions and IND-enabling studies for lead candidate CLD-401, with a filing expected by end…

FridayJun 27, 2025 9:56 am

NetworkNewsBreaks – Latin Metals Inc. (TSX.V: LMS) (OTCQB: LMSQF) Secures 100% Ownership of Cerro Bayo Silver-Gold Project

Latin Metals (TSX.V: LMS) (OTCQB: LMSQF) announced it has signed an amended agreement to acquire the remaining 29% interest in the Cerro Bayo and La Flora properties in Argentina’s Santa Cruz Province, making it the sole owner of the fully permitted, drill-ready silver-gold exploration asset. The revised deal with Tres Cerros Exploraciones S.R.L. includes staged cash payments totaling US$400,000 through 2027. TCE will retain a 0.75% NSR royalty, of which 0.5% can be repurchased by Latin Metals for US$1 million. To view the full press release, visit https://nnw.fm/e549X About Latin Metals Latin Metals Inc. is a copper, gold and silver…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks